282 related articles for article (PubMed ID: 31874262)
1. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database.
Zhang N; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Int J Surg; 2020 Feb; 74():44-52. PubMed ID: 31874262
[TBL] [Abstract][Full Text] [Related]
2. Negative Lymph Node Is an Independent Prognostic Factor for Stage III Gastric Cancer Patients After Curative Gastrectomy: A Surveillance, Epidemiology, and End Results-Based Study.
Liu L; Ren J; Wang G; Cui Y; Li F; Wang D; Lei X
Am Surg; 2023 Nov; 89(11):4413-4423. PubMed ID: 35861326
[TBL] [Abstract][Full Text] [Related]
3. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
4. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
[TBL] [Abstract][Full Text] [Related]
5. Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study.
Jiang J; Chen J; Zhang H; Rao X; Hao T; Li M; Zhang C; Wu W; He Y
J Gastrointest Oncol; 2021 Oct; 12(5):2022-2034. PubMed ID: 34790370
[TBL] [Abstract][Full Text] [Related]
6. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
[TBL] [Abstract][Full Text] [Related]
7. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system.
Deng J; Liu J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
Chin J Cancer Res; 2018 Oct; 30(5):477-491. PubMed ID: 30510359
[TBL] [Abstract][Full Text] [Related]
8. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes.
Deng J; Liang H; Wang D; Sun D; Ding X; Pan Y; Liu X
Ann Surg Oncol; 2010 Apr; 17(4):1043-51. PubMed ID: 20039218
[TBL] [Abstract][Full Text] [Related]
9. Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients.
Deng J; Yamashita H; Seto Y; Liang H
Ann Surg Oncol; 2017 Mar; 24(3):745-753. PubMed ID: 27770340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.
Jiao XG; Deng JY; Zhang RP; Wu LL; Wang L; Liu HG; Hao XS; Liang H
World J Gastroenterol; 2014 Apr; 20(13):3640-8. PubMed ID: 24707149
[TBL] [Abstract][Full Text] [Related]
11. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer.
Liu H; Deng J; Zhang R; Hao X; Jiao X; Liang H
Int J Surg; 2013; 11(5):419-24. PubMed ID: 23541652
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study.
He Z; Li D; Xu Y; Wang H; Gao J; Zhang Z; Chen K
Scand J Gastroenterol; 2022 Jul; 57(7):832-841. PubMed ID: 35293268
[TBL] [Abstract][Full Text] [Related]
13. Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy.
Shi RL; Chen Q; Ding JB; Yang Z; Pan G; Jiang D; Liu W
Oncotarget; 2016 Jun; 7(23):35084-91. PubMed ID: 27147564
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of negative lymph node count for patients with gastric cancer who received preoperative radiotherapy.
Li X; Zhang W; Zhang X; Wang H; Xu K; Yao H; Yao J; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):46946-46954. PubMed ID: 28159939
[TBL] [Abstract][Full Text] [Related]
15. Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon.
Kuo YH; You JF; Hung HY; Chin CC; Chiang JM; Chang CH
BMC Cancer; 2022 Jan; 22(1):126. PubMed ID: 35100975
[TBL] [Abstract][Full Text] [Related]
16. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
[TBL] [Abstract][Full Text] [Related]
17. Impact of the extent of negative lymph nodes in gastric adenocarcinoma undergoing primary surgical resection: An institutional report.
Chen YJ; Yeh ST; Ou LH; Lin CS; Chien CT
J Chin Med Assoc; 2021 Apr; 84(4):428-437. PubMed ID: 33595989
[TBL] [Abstract][Full Text] [Related]
18. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
Smith DD; Schwarz RR; Schwarz RE
J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
